#20: H/X @ ASCO 2012 Partnering Forum

Healthios Capital Markets, a Chicago-based boutique investment bank focused exclusively on the emerging healthcare community, is proud to announce the firm's exclusive partnering event preceding ASCO, entitled "H/X @ ASCO 2012." Healthios will be hosting the event at the prestigious Union League Club, 65 W. Jackson, in downtown Chicago.

To kick off our Healthios Partnering meeting at 11:45 a.m. on Friday, June 1, Verastem's senior management team will keynote H/X @ ASCO 2012 over lunch by presenting its case study, "Verastem: Inception to IPO," chronicling the January 2012 IPO for this cancer stem cell company (http://www.verastem.com).

Along with confirmed “Strategics,” Abbott Laboratories, Astellas Pharma, Genentech, Hoffmann-La Roche, Merck, Millennium Pharmaceuticals, Novartis, Pfizer, Sanofi-Aventis, and Teva Pharmaceuticals, attendees will be joined by other distinguished leaders who are eager to meet one-on-one with the CEOs of the top-tier, venture-backed emerging growth companies in Oncology.

On Friday, June 1, attendees will have the opportunity to meet privately for 30 minutes with up to eight emerging growth companies. Attendees will have access to the companies' non-confidential management presentations on our research portal (www.healthios.com/hx).

Healthios is an investment bank focused exclusively on the emerging growth healthcare community: strategic buyers, institutional investors and their portfolio companies - with a practice dedicated to Oncology Therapeutics. The Healthios Exchange ("H/X") is a unique research platform which enables invited users to access the resources, research and relationships which are fundamental to superior value creation. Our partnering events are extensions of the H/X, as we believe partnering to be at the core of innovative new medicines in Oncology.